Management of Irritable Bowel Syndrome: The Role of Digital Health Technologies.

IF 2

Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2025-09-26 DOI:10.15403/jgld-6189

Arjuna Priyadarsin De Silva, Krishanni Prabagar, Madunil Anuk Niriella, Hithanadura Janaka De Silva

{"title":"Management of Irritable Bowel Syndrome: The Role of Digital Health Technologies.","authors":"Arjuna Priyadarsin De Silva, Krishanni Prabagar, Madunil Anuk Niriella, Hithanadura Janaka De Silva","doi":"10.15403/jgld-6189","DOIUrl":null,"url":null,"abstract":"<p><p>Functional Gastrointestinal Disorders (FGIDs), including conditions such as irritable bowel syndrome (IBS) and functional dyspepsia, affect millions worldwide, significantly impairing quality of life and increasing healthcare utilization. These disorders are multifactorial and complex, with several subtypes, making diagnosis and management challenging. This review explores the emerging role of digital health technologies and artificial intelligence(AI) in transforming FGID diagnosis and treatment. We focus on wearable devices, capsule-based diagnostics, mobile health applications, and AI-powered virtual assistants, highlighting how these innovations address the limitations of traditional investigative and management approaches. Additionally, we assess the impact of these digital advancements on patient outcomes, healthcare efficiency, and real-time symptom monitoring. Finally, we examine the challenges associated with data privacy, accuracy, and reliability in digital health solutions and propose future directions for technological advancements in FGID management.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"34 3","pages":"275-278"},"PeriodicalIF":2.0000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gastrointestinal and liver diseases : JGLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15403/jgld-6189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Functional Gastrointestinal Disorders (FGIDs), including conditions such as irritable bowel syndrome (IBS) and functional dyspepsia, affect millions worldwide, significantly impairing quality of life and increasing healthcare utilization. These disorders are multifactorial and complex, with several subtypes, making diagnosis and management challenging. This review explores the emerging role of digital health technologies and artificial intelligence(AI) in transforming FGID diagnosis and treatment. We focus on wearable devices, capsule-based diagnostics, mobile health applications, and AI-powered virtual assistants, highlighting how these innovations address the limitations of traditional investigative and management approaches. Additionally, we assess the impact of these digital advancements on patient outcomes, healthcare efficiency, and real-time symptom monitoring. Finally, we examine the challenges associated with data privacy, accuracy, and reliability in digital health solutions and propose future directions for technological advancements in FGID management.

查看原文本刊更多论文

肠易激综合征的管理：数字健康技术的作用。

功能性胃肠疾病（fgid），包括肠易激综合征（IBS）和功能性消化不良等疾病，影响着全球数百万人的生活质量，并增加了对医疗保健的利用。这些疾病是多因素和复杂的，有几个亚型，使诊断和管理具有挑战性。这篇综述探讨了数字卫生技术和人工智能（AI）在改变FGID诊断和治疗中的新兴作用。我们将重点关注可穿戴设备、基于胶囊的诊断、移动健康应用程序和人工智能驱动的虚拟助手，重点介绍这些创新如何解决传统调查和管理方法的局限性。此外，我们还评估了这些数字进步对患者结果、医疗效率和实时症状监测的影响。最后，我们研究了数字健康解决方案中与数据隐私、准确性和可靠性相关的挑战，并提出了FGID管理技术进步的未来方向。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of gastrointestinal and liver diseases : JGLD

自引率

0.00%

发文量